The big story on Wednesday was IBM’s gain, which helped the Dow achieve a new milestone. That’s why in this overbought market, your best bets are the blue chips. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Strong earnings and a resurgent tech sector continue to propel stocks forward, but many dangers are coming to the fore. Here’s what the closing numbers on Tuesday really mean. Read More
The markets set new records on Monday, on the strength of a robust third-quarter earnings season and positive data from China. Read More
As third-quarter corporate scorecards start pouring in this week, the real news for investors is international expansion, not monetary and fiscal policy in the U.S. Read More
Yield-hungry investors are ignoring history and flocking to highly risky assets. Get smart, by making these seven moves for crash protection as well as higher income. Read More
Some investors are getting spooked by this tech innovator’s patent disputes with Apple, Samsung and AT&T, but we’re not overly concerned. Read More
Marijuana stocks are all the rage, as investors fixate on the growth potential of legalized weed. Here’s a small-cap biotech that’s disrupting the pot as well as tobacco industries. Read More
Tax changes now in the air threaten to eat away at your investments. With these three safe income plays, you can protect your dividend portfolio from the claws of the IRS. Read More
One of the surest ways to reap rapid profits is to invest in entrepreneurial drug makers that target unmet needs. We highlight enticing small-cap plays that are ready to soar. Read More
This week, Obamacare is proving to be untouchable yet again. While lawmakers get zapped trying to replace it, you can make money. Read More